We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
Transition to a fermentation-based globally integrated CDMO platform
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
This transaction fundamentally strengthens Scinai's CDMO platform
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Reported profit after tax declined 19% year-on-year to Rs 76 crores
The state-of-the-art facility is equipped with best-in-class equipment and control systems
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
